On August 12, the awarding ceremony for the National Model Pharmaceutical Company for Quality Credit Development was held in Changzhou, Jiangsu. Yangtze River Pharmaceutical Group, which was among the first group of National Model Pharmaceutical Companies for Quality Credit Development in 2006, successfully passed the check to win the National Model Pharmaceutical Company for Quality Credit Development. The conference also awarded the 13 companies that have met the requirement and presented the plaques. The forum was held by China Medical Quality Management Association. Yangtze River Pharmaceutical Group's Chairman Xu Jingren attended the conference and shared his views and experience.
Yangtze River Pharmaceutical Group is a large pharmaceutical company in China. Over the 40 years since its establishment, Yangtze River Pharmaceutical Group has been focusing on the quality credit development by upholding the principles of "seek progress all the time and protecting all human beings" and "benefit the public through quality and innovation" and has been making great strides. Since 2009, Yangtze River Pharmaceutical Group has been among the top three of Top 100 Companies in Pharmaceutical Industry in China for four consecutive years. To safeguard product quality and forge creditworthy brand, Yangtze River Pharmaceutical Group has built a quality management system that governs the whole procedures from production to after-sale service, sticking to the EU GMP and China's new GMP as its quality management and ensuring the 100% perfection rate. During the course of quality management, Yangtze River Pharmaceutical Group intensifies its efforts on the quality months, which are held twice a year, and the QC team activities while nurturing its quality brands. The Company has won titles such as National Pharmaceutical Industry Excellent Company for QC Team Activities, Best Organization Prize for Quality Management, Excellent Company for Implementing Excellent Performance Model, Jiangsu Excellent Quality Management Award, Mayor of Taizhou Quality Prize, has been the biggest winner of first prize in National Pharmaceutical Industry QC Team Results for nine consecutive years. Its Weisu granule won No.1 Satisfactory Product in Chinese Pharmaceutical Product Market, Gingko Leave tablet and Weidi were rated the Ninth Safe Medicine by the public. Yangtze River Pharmaceutical Group has occupied a commanding position in pharmaceutical product market with its good product quality and reliable brand image among its consumers, being a banner of China's national pharmaceutical industry.
The focus on improving quality and being creditworthy were keys to Yangtze River Pharmaceutical Group's success in market. Yangtze River Pharmaceutical Group has long been regulating its staff's words and deeds with honest and creditworthy codes and values. Yangtze River Pharmaceutical Group requires every of its sales persons to work by law and behave honestly. The Company holds a monthly collective study of the policies, documents, regulations and laws released from the State Council and medical and health department by mobilizing its sales staff and teaching them the law-abiding operation and honest promotion. To strengthen the law-abiding awareness of its sales personnel, Yangtze River Pharmaceutical Group also invites experts from the court and precuratorates to give lessons on legal issues on how to stay away from illegal activities. The Company also sends personnel from supervision and market monitoring division to check and supervise the salespersons' promoting practice, market operation and sales contract so at to further regulate and supervise the market and ensure legal and honest operation.
Xu Jingren, Chairman of Yangtze River Pharmaceutical Group, said that winning the National Model Pharmaceutical Company for Quality Credit Development is an encouragement and inspiration to the Company. From now on, Yangtze River Pharmaceutical Group would continue to uphold the principle of prioritizing the quality and creditworthiness and conduct the one-off evaluation of product quality and law enforcement campaigns. Yangtze River Pharmaceutical Group would take the quality of international pharmaceutical giants as their benchmark, introduce the advanced ideas on quality management and close the gap between its quality management level with international standards so as to build core competitiveness of a company and become a world-class company.